Ubs Asset Management Americas Inc Emergent Bio Solutions Inc. Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$3.17 - $7.91 $39,647 - $98,930	12,507 Added 27.7%	57,653 $196,000
Q1 2023 May 15, 2023	SELL	$7.79 - $16.29 $24,133 - $50,466	-3,098 Reduced 6.42%	45,146 $467,000
Q4 2022 Feb 14, 2023	SELL	$11.0 - $21.45 $27,929 - $54,461	-2,539 Reduced 5.0%	48,244 $569,000
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $36,282 - $64,654	-1,806 Reduced 3.43%	50,783 $1.07 Million
Q2 2022 Aug 12, 2022	SELL	$27.42 - $43.63 $276,421 - $439,834	-10,081 Reduced 16.09%	52,589 $1.63 Million
Q1 2022 May 16, 2022	BUY	$36.48 - $52.22 $443,086 - $634,264	12,146 Added 24.04%	62,670 $2.57 Million
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $254,483 - $422,806	-7,686 Reduced 13.2%	50,524 $2.2 Million
Q3 2021 Nov 15, 2021	SELL	$50.07 - $66.05 $41,457 - $54,689	-828 Reduced 1.4%	58,210 $2.91 Million
Q2 2021 Aug 16, 2021	SELL	$56.61 - $80.46 $417,102 - $592,829	-7,368 Reduced 11.1%	59,038 $3.72 Million
Q1 2021 May 14, 2021	SELL	$86.23 - $125.19 $378,980 - $550,210	-4,395 Reduced 6.21%	66,406 $6.17 Million
Q4 2020 Mar 01, 2021	BUY	$79.17 - $111.47 $349,456 - $492,028	4,414 Added 6.65%	70,801 $6.34 Million
Q3 2020 Nov 13, 2020	SELL	$81.91 - $134.94 $83,630 - $137,773	-1,021 Reduced 1.51%	66,387 $6.86 Million
Q2 2020 Aug 14, 2020	SELL	$54.33 - $89.52 $352,004 - $580,000	-6,479 Reduced 8.77%	67,408 $5.33 Million
Q1 2020 May 15, 2020	BUY	$49.34 - $68.76 $250,055 - $348,475	5,068 Added 7.36%	73,887 $4.28 Million
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $840,765 - $969,647	-16,418 Reduced 19.26%	68,819 $3.71 Million
Q3 2019 Nov 14, 2019	BUY	$40.6 - $57.2 $246,766 - $347,661	6,078 Added 7.68%	85,237 $4.46 Million
Q2 2019 Aug 15, 2019	BUY	$39.92 - $53.86 $1.11 Million - $1.5 Million	27,813 Added 54.17%	79,159 $0
Q1 2019 May 14, 2019	BUY	$48.23 - $66.16 $75,672 - $103,805	1,569 Added 3.15%	51,346 $0
Q4 2018 Feb 13, 2019	BUY	$55.63 - $73.24 $179,684 - $236,565	3,230 Added 6.94%	49,777 $2.95 Million
Q3 2018 Nov 14, 2018	SELL	$52.05 - $66.51 $3,123 - $3,990	-60 Reduced 0.13%	46,547 $0
Q2 2018 Aug 14, 2018	BUY	$48.33 - $55.64 $171,329 - $197,243	3,545 Added 8.23%	46,607 $0
Q1 2018 May 14, 2018	SELL	$44.44 - $54.39 $19.5 Million - $23.9 Million	-438,745 Reduced 91.06%	43,062 $0
Q4 2017 Feb 09, 2018	SELL	$37.77 - $47.75 $2.71 Million - $3.42 Million	-71,713 Reduced 12.96%	481,807 $0
Q3 2017 Nov 13, 2017	BUY	$34.14 - $40.45 $18.9 Million - $22.4 Million	553,520	553,520 $0

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$33.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$29.9 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21.9 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$19.6 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.8 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account